Differences in antigenicity of E2 in Semliki Forest virus particles and in infected cells
- PMID: 7526823
- PMCID: PMC7086913
- DOI: 10.1007/BF01310027
Differences in antigenicity of E2 in Semliki Forest virus particles and in infected cells
Abstract
Using six monoclonal antibodies to epitopes a-f on the glycoprotein E2 of Semliki Forest virus (SFV) we found antigenic differences between E2 in infected cells and in virus particles, respectively, if glycosylation was impaired by 2-deoxy-D-glucose or inhibited by N-methyl-1-deoxynojirimycin. Furthermore we concluded that a conformational change of E2 takes place on virus budding.
Similar articles
-
The significance of carbohydrate trimming for the antigenicity of the Semliki Forest virus glycoprotein E2.Virology. 1990 Jun;176(2):369-78. doi: 10.1016/0042-6822(90)90007-e. Virology. 1990. PMID: 1693245
-
Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities.J Virol. 1984 Nov;52(2):575-82. doi: 10.1128/JVI.52.2.575-582.1984. J Virol. 1984. PMID: 6208379 Free PMC article.
-
Serologically defined linear epitopes in the E2 envelope glycoprotein of Semliki Forest virus.Arch Virol. 1990;113(1-2):99-106. doi: 10.1007/BF01318358. Arch Virol. 1990. PMID: 1696808
-
Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine.J Gen Virol. 1991 Mar;72 ( Pt 3):557-65. doi: 10.1099/0022-1317-72-3-557. J Gen Virol. 1991. PMID: 1706409
-
Antigenic differences between virulent and avirulent strains of Semliki Forest viruses detected with monoclonal antibodies. Brief report.Arch Virol. 1986;88(1-2):105-12. doi: 10.1007/BF01310894. Arch Virol. 1986. PMID: 2420309
Cited by
-
The 6-kilodalton membrane protein of Semliki Forest virus is involved in the budding process.J Virol. 1995 Jan;69(1):469-75. doi: 10.1128/JVI.69.1.469-475.1995. J Virol. 1995. PMID: 7983743 Free PMC article.
References
-
- Fenouillet E, Gluckman JC. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein. J Gen Virol. 1991;72:1919–1926. - PubMed
-
- Kaluza G, Scholtissek C, Rott R. Inhibition of the multiplication of enveloped RNA-viruses by glucosamine and 2-deoxy-D-glucose. J Gen Virol. 1972;14:251–259. - PubMed
-
- Kaluza G, Rott R, Schwarz RT. Carbohydrate-induced conformational changes of Semliki Forest virus glycoproteins determine antigenicity. Virology. 1980;102:286–299. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources